GlassScriptPhysician profile
Amarnath V Ramakrishnan
NPI 1215959143
$3,300.07
in general payments reported to CMS, 2019-2025
18 companies · $604 in 2025
The $604 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $26.20 · 2021: $415 · 2022: $485 · 2023: $1,130 · 2024: $282 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,710 · Travel and Lodging: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,709.79 |
| Travel and Lodging | $305.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,333.24 | 2019-2025 | Exalt Model D, General - Therapies, Axios |
| Abbvie INC. | $328.86 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $252.30 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $242.15 | 2022-2025 | Tremfya, Stelara |
| Enterra Medical, INC. | $167.11 | 2023 | |
| Pfizer INC. | $165.99 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $149.99 | 2023 | Rebyota |
| E.R. Squibb & Sons, L.L.C. | $136.31 | 2021 | |
| Davol INC. | $125.52 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.58 | 2020-2021 | |
| Celgene Corporation | $77.14 | 2021-2023 | |
| Endogastric Solutions, INC | $67.27 | 2021 | |
| Omega Medical Imaging, LLC | $46.30 | 2023 | |
| Madrigal Pharmaceuticals | $25.76 | 2025 | Rezdiffra |
| Stryker Corporation | $22.59 | 2023 | Neptune |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $20.03 | 2023 | Ibsrela |
| Medtronic, INC. | $15.73 | 2021 | |
| Shire North American Group INC | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarnath Ramakrishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.